<DOC>
	<DOCNO>NCT00870493</DOCNO>
	<brief_summary>Immunoglobulin A ( IgA ) nephropathy common type primary glomerulonephritis world . Current treatment angiotensin convert enzyme ( ACE ) inhibitor angiotensin receptor blocker ( ARB ) entirely effective . Aliskiren , direct renin inhibitor , act rate limit step renin-angiotensin axis . In addition lower blood pressure , recent study diabetic nephropathy suggest independent anti-proteinuric effect . The investigator plan conduct randomized placebo-control cross-over study evaluate safety efficacy aliskiren treatment IgA nephropathy . The investigator plan recruit 57 patient biopsy-proven IgA nephropathy persistent proteinuria despite conventional therapy . They randomize aliskiren 16 week treatment , follow cross arm washout period . Proteinuria , albuminuria , renal function , serum urinary marker quantify . This study explore potential anti-proteinuric effect aliskiren treatment IgA nephropathy , specific treatment present .</brief_summary>
	<brief_title>Aliskiren Immunoglobulin A ( IgA ) Nephropathy</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Glomerulonephritis , IGA</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulin A</mesh_term>
	<criteria>age 1865 year require antihypertensive therapy renal biopsy within past 3 year confirm diagnosis IgA nephropathy proteinuria &gt; 1 g/day ( proteinuria &gt; 1 g/gCr ) 3 consecutive sample within 12 week despite ACE inhibitor ARB treatment least 3 month estimate glomerular filtration rate &gt; 30 ml/min/1.73m2 willingness give write consent comply study protocol Patients diabetic , patient systemic disease may cause IgA nephropathy another nephropathy . Pregnancy , lactate childbearing potential without effective method birth control Severe gastrointestinal disorder interfere ability receive absorb oral medication History malignancy , include leukemia lymphoma within past 2 year Systemic infection require therapy study entry Any severe coexisting disease , limited , chronic liver disease , myocardial infarction , cerebrovascular accident , malignant hypertension History drug alcohol abuse within past 2 year Participation previous trial aliskiren renin inhibitor Previous treatment fish oil , steroid , cytotoxic agent , aldosterone antagonist History treatment drug may affect proteinuria within past 2 year Patients receive treatment corticosteroid On investigational drug within last 30 day History psychological illness condition interfere patient 's ability understand requirement study History noncompliance Known history sensitivity allergy aliskiren renin inhibitor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>proteinuria</keyword>
	<keyword>renal failure</keyword>
	<keyword>glomerulonephritis</keyword>
</DOC>